PHARMACEUTICALS

Localizing the pharmaceutical industry is a key priority for the Saudi government as part of Vision 2030. Today, only 30% of pharmaceutical products are manufactured locally. In 2016, the pharmaceutical market was worth $8.1 billion, making it the largest pharmaceutical market in the GCC. The per capita drug spending in the Kingdom is 113% higher than the global average.

Cumulative government spending on pharmaceuticals from 2017-2021 will be worth $42 billion.


PHARMACEUTICALS MARKET SIZE

Cumulative Government expenditure over 2017-2021
$42 bn


2016
7.4 bn

2021
9.3 bn


KEY INFRASTRUCTURE

Spend on Patient Drugs in 2016
$4.1 bn


Spend on Generic Drugs in 2016
$2.3 bn


Spend on Over the Counter in 2016
$1.0 bn

LOCALIZATION OPPORTUNITIES

  • Vaccines
  • Biologics & Biosimilars
  • Sterile Injectables
  • APIs
  • Solid Oral Dosages

Source: BMI, Ministry of Health (MoH)